Table 3.
Progression-free survival and overall survival by LCS6 genotype and treatment
| LCS6 genotype | N | Arm | Median months | 95% CI | Interaction P value |
|---|---|---|---|---|---|
|
Progression-free survival | |||||
| Wild-type |
154 |
A |
7.9 |
7.2-8.5 |
0.63 |
| 297 |
B+C |
7.7 |
7.2-8.3 |
||
| Variant |
26 |
A |
7.7 |
3.8 – 11.6 |
|
| 58 |
B+C |
8.5 |
7.0-10.0 |
||
|
Overall survival | |||||
| Wild-type |
154 |
A |
20.4 |
16.5 – 24.2 |
0.50 |
| 297 |
B+C |
18.9 |
16.9 – 20.9 |
||
| Variant |
26 |
A |
22.3 |
13.2 – 31.4 |
|
| 58 | B+C | 23.5 | 19.9 – 27.1 | ||